SCHEMBL17381663

SCHEMBL17381663

NC(=O)OCc1cn([C@H]2C[C@@H](NC(=O)c3cc(-c4ccccc4)on3)C2)nn1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 7/20 0.50
▸ RAB9A P51151 7/20 0.50
▸ S1PR1 P21453 1/20 0.49
▸ FAAH O00519 2/20 0.46
▸ USP30 Q70CQ3 1/20 0.45
▸ MLLT1 Q03111 4/20 0.44
▸ MLLT3 P42568 1/20 0.43
▸ HIF1A Q16665 3/20 0.42
▸ KMT2A Q03164 4/20 0.42
▸ LMNA P02545 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.40
▸ TP53 P04637 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17381661 1.00 NPC1 (0.50) NPC1RAB9AS1PR1FAAHUSP30
SCHEMBL17374183 0.87 RAB9A (0.55) NPC1RAB9AS1PR1FAAHUSP30
SCHEMBL17374428 0.87 RAB9A (0.55) NPC1RAB9AS1PR1FAAHUSP30
SCHEMBL17374180 0.87 RAB9A (0.55) NPC1RAB9AS1PR1FAAHUSP30
SCHEMBL20200063 0.86 RAB9A (0.54) NPC1RAB9AS1PR1FAAHUSP30
SCHEMBL20200054 0.86 RAB9A (0.54) NPC1RAB9AS1PR1FAAHUSP30
SCHEMBL19239573 0.86 RAB9A (0.45) NPC1RAB9AS1PR1FAAHUSP30
SCHEMBL17374593 0.86 RAB9A (0.45) NPC1RAB9AS1PR1FAAHUSP30
SCHEMBL17374592 0.86 RAB9A (0.45) NPC1RAB9AS1PR1FAAHUSP30
SCHEMBL17374601 0.85 RAB9A (0.53) NPC1RAB9AS1PR1FAAHUSP30

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015196071-A9 COMPOUNDS, COMPOSITIONS AND METHODS OF INCREASING CFTR ACTIVITY PROTEOSTASIS THERAPEUTICS, INC. (US) 2016-02-18 — — WO disclosed
WO-2015196071-A1 COMPOUNDS, COMPOSITIONS AND METHODS OF INCREASING CFTR ACTIVITY PROTEOSTASIS THERAPEUTICS, INC. (US) 2015-12-23 — — WO disclosed
Send feedback